Does crosslinking of collagen type ! with EDC NHS cause osteogenic differentiation of MSCs?
Crosslinking of collagen type I with EDC/NHS has been shown to impact osteogenic differentiation of mesenchymal stem cells (MSCs). Studies have demonstrated that collagen-based scaffolds, when crosslinked using different methods like genipin or EDC/NHS, can influence the adhesion, proliferation, and osteogenic differentiation of MSCs . While the mechanical properties of the scaffolds remain relatively stable post-crosslinking, changes in scaffold chemistry affect cellular behaviors such as adhesion and differentiation of MSCs . Inhibition of collagen crosslinking has been found to impair the osteogenic program in pre-osteoblast cells, indicating that collagen crosslinking plays an instructive role in differentiation processes . Therefore, crosslinking of collagen type I with EDC/NHS can indeed influence the osteogenic differentiation of MSCs, highlighting the importance of scaffold chemistry in tissue engineering applications.
Answers from top 5 papers
Papers (5) | Insight |
---|---|
Crosslinking collagen type I with EDC/NHS does not directly cause osteogenic differentiation of MSCs. However, it promotes cell adhesion, viability, and vascularization, enhancing bone regeneration potential. | |
Yes, crosslinking collagen type I with EDC NHS promotes osteogenic differentiation of MSCs on nanofiber matrices, enhancing adhesion, proliferation, and expression of osteogenic markers like ALP and mineralization. | |
49 Citations | Not addressed in the paper. |
24 Citations | Crosslinking collagen type I with EDC NHS was not specifically studied in the paper. However, crosslinking with different methods did not hinder osteogenic differentiation of MSCs in recombinant peptide scaffolds. |
1 Citations | Crosslinking collagen with EDC NHS in a scaffold with carboxymethyl chitosan and hyaluronic acid promotes osteogenic differentiation of BMSCs, enhancing adhesion, proliferation, and osteogenic markers secretion. |